[1] The goal of this paper is to provide information on
some ways in which technology is impacting fundamental questions
that affect how we view nature and humanity. Science impacts
humanity in many broad ways, providing a greater understanding of
the world around us. Each person is impacted by changes in
medical practice regarding new diagnostic tools and new therapeutic
approaches. These changes are sometimes positive, such as the
massive improvement in survival rate and disease-free survival that
we have observed in cancer medicine of the past few decades; and
sometimes negative, such as the clash between the quality of life
and end of life care that plague anyone who is tending to the
terminally ill. Moreover, in some cases it is still too early
to determine to what end the consequences of the new
development will lead. For example, the genome initiative that
led to the sequencing of the human genome has altered our
approaches to genetic diseases, and the fruits of this technology
have not yet been fully observed. Newer technologies such as
in vitro fertilization, cloning of cells and animals, and stem cell
research are still being debated even while some aspects of these
technologies are only beginning to be implemented. Our
environment is impacted daily by the development of genetically
engineered, recombinant crops and farm animals. All of these
are just a few examples of how science touches our lives each
day.
[2] It is in the light of these perspectives that I wish to
examine how technology impacts and is likely to impact our
lives. The four major questions to be postulated and used to
shape the discussion are:
2 Nature or nurture? (i.e., how much of a person's
psycho-physical make-up or phenotype is determined by nature and
how much is determined by nurture?)
3. How far is too far? (or, should we limit
technology?)
What is normal?
[3] The question of what is normal and what is abnormal is
one that will have new meaning because of work with the human
genome. When we examine DNA sequences, it is difficult to
discern up-front which sequences can be considered to be variants
of normal and which ones lead to development of disease. In
most cases there is more than one version of the gene; in most
cases more than one version of the gene is functionally
correct. If we were to claim that there is always only one
sequence that is "norma," then which sequence for eye color would
be the "normal" one: brown eyes or blue eyes? This is an
obvious case where we can claim that both sequences are variants of
normal. Nevertheless, for other situations where the genes
have unknown functions or multiple functions, this judgment becomes
more difficult.
[4] Let us start with an introduction into the genetic
material. We know that the genetic material deoxyribonucleic
acid (DNA) is composed of a sugar (deoxyribose), a base, and a
phosphodiester backbone (for a review of this and below
information, see endnote 1). There are four bases that make up
the major constituents of DNA, and these four bases are represented
by the letters A, T, G, and C. The genetic code from DNA gets
transcribed into RNAs, and base triplets get translated into single
amino acids of proteins; therefore the order of the bases
determines what protein will be made. The codon sequence of
TTT encodes a different amino acid and thus a different final
protein than the sequence AAA. Different arrangements of bases
in DNA make for different arrangements of amino acids and thus
different proteins. Figures 1A
and 1B
show an outline of the central dogma of molecular biology. In Fig. 1A
we see the usual pattern which is that DNA makes (through the
process of transcription) RNA which makes (through the process of
translation) protein. The DNA itself has a coding region that
makes the protein and a regulatory region (also called a promoter)
that defines how the gene will be expressed-i.e., which tissues
will make the protein, when in development it will be made, what
environmental factors will regulate it, etc. Figure 1B
shows how mutations in DNA can affect any part of this
process. A mutation is defined as a(ny) change from the normal
sequence. A mutation in the coding region can lead to several
possible consequences: (1) a silent mutation which will not be
observed; (2) a change in the amino acid sequence of the protein
which can lead to a change in protein structure and function; (3) a
change in amino acid sequence so that the protein is truncated and
only a portion of it is synthesized. The latter two types of
mutations may have massive or minor consequences for the body
depending on the gene, the mutation, other genes and the
environment of the individual. Alternatively, a mutation in a
regulatory region may lead to a change in the activity of a gene
causing the gene to be expressed at inappropriate levels or in
inappropriate locations of the body.
[5] Based on this understanding, then, whenever a genetic
mutation leads to a silent mutation such mutation is just a genetic
variation from one person to another. For example the sequence
ATCATCTTT codes for the amino acids
Isoleucine-Isoleucine-Phenylalanine. The sequence ATCATTTTT
also codes for the same amino acids. Two people with these two
slightly different genomic sequences would make the same
protein. Which of these two is the "normal" sequence? Is
it the one that is most common in the human population? Is it
the one that is most ancient in the population? Clearly, if we
think about it from a disease perspective, both sequences are
normal.
[6] Let's move on to a more difficult example, where the
mutation is not silent. For example, the ABO blood groups are
caused by changes in DNA sequence that result in changes of the
proteins. People with the A blood group have the sequence
GTGACCCTTT which makes Val-Thr-Pro. People with a single
deletion of one DNA base G have an entirely different
sequence: Val-Pro-Leu. We know that both of these blood
groups occur in the human species and that the O type is more
common, yet we consider these different sequences normal variations
in the human population.
[7] In all species with segmented body parts, the structure
of the body form is regulated by a series of so-called Hox
genes. A change in one of these genes in the fruit fly can
lead to an antenna being replaced by a leg and more pronounced
genetic abnormalities can result depending on the exact
mutation. In humans, developmental abnormalities have been
associated with some differences in Hox genes as well. Many
times these are very pronounced, but sometimes they are less
obvious. Fig. 2
shows a picture of my dog Jessie who has five toes on her front
left foot, but only four on her front right foot. Most dogs
have either one or the other number of toes on both front legs, but
she has a combination probably as a difference in a Hox
gene. Which one of these is normal? Since both variations
exist in the dog population, it is difficult to define what is
normal and what is abnormal here.
[8] Based on these normal variations, most scientists tend
to call frequent mutations that do not cause disease "alleles" and
consider them normal, and whatever mutations give rise to
disease "mutations" and consider them abnormal, but this division
is not clear in all cases because of the interplay between genes
and environment. Usually, if a gene confers a benefit it is
kept in the gene pool, and if it conveys only deleterious
consequences it is lost because it results in a reduced ability of
an individual to survive long enough to have offspring. For
example, the gene for globin encodes the major protein found in red
blood cells that carries out the task of supplying oxygen to the
body. When this gene is mutated in both gene copies in the
genome, as for example in sickle cell anemia, anemia
results. While this mutation clearly leads to development of
disease, it is present in the human population in such a high
frequency that we would expect it to be harmless. How is this
possible? In areas where malaria is endemic (such as in Africa
and portions of southeast Asia), people with the sickle cell globin
gene are resistant to malaria. This means that people with two
"normal" copies of the globin gene will die from malaria, and
people with two copies of the sickle globin gene will die from
sickle cell anemia. The only people who will be healthy in a
malaria-prone environment are those with one "normal" copy and one
sickle cell copy of the gene; these people will not develop malaria
and will not have sickle cell disease. In our environment in
North America, we have chosen to call the sequence of the gene for
non-sickle globin "normal," but in Africa this designation needs to
be reconsidered.
[9] In other diseases, such as Cystic Fibrosis where there
is a deletion of three bases in many cases, this deletion clearly
leads to a difference in the amino acid sequence of a protein which
results in Cystic Fibrosis. Medical specialists have chosen to
call the gene that does not give rise to Cystic Fibrosis "normal"
and the gene that gives rise to the disease "mutant." Was
there some benefit to this mutation in the human population that we
have not yet identified and would have made this mutation "normal"
in some other environment? Interestingly, even the trappings
of society sometimes provide the "environment" where a harmful
mutation can have increased frequency. Royal families of
Europe have, for example, perpetuated the gene for hemophilia in
their efforts to intermarry only with other "royal blood
lines."
[10] Based on all of the above, probably one of the most
important consequences of the completion of the human genome
sequence will be in the identification of the spectra of possible
gene variations and discovering which gene allele pairs are
harmless in which environments, and then "proclaim" what is normal
and what is not. As we identify the genes for not just
physical but also psychological diseases, and discover which
combinations of genes influence complex phenotypic traits, the
definition of what is "normal" and what is "abnormal" may become
blurred. Will we begin to define diseases based on genetics,
especially for psychosocial diseases? How will we
differentiate between a polymorphism (existence of two or more
healthy alleles for one gene) from a normal gene with its
mutations? What is the role of these genetic mutations in
defining who we are?
[11] To answer these questions, we will probably need to
come out of our shells as scientists and become more
contemplative. Patriarch Ignatius of Antioch
wrote: "Contemplation of nature transforms nature, not in the
direction of Babel, but in the direction of the New
Jerusalem. When an Orthodox hermit, well into the twentieth
century gives poisonous snakes little cups of milk to drink, he
knows them in a different way than the
scientist¼" (2). We will perhaps need to
learn about mutations in a different way than we have learned them
before in order to put them in their proper context.
Nature or nurture?
[12] This question has probably been the most important
question that has plagued biologists in recent decades. How
much of who we are is environmentally determined and how much is
determined by our genetics? Thinking in this area has so far
been shaped by studies of identical twins separated at birth and
this area of research is likely to be much influenced in the future
by studies of non-related individuals with large clusters of
identical genes considered to regulate social behavior and
anti-social activity, and mental and psychological diseases.
[13] Identical twins have identical sequences in their
genetic code; they are in effect clones of each other. A large
number of studies have been done examining identical twins that
have been raised apart, and in particular the Minnesota Twin Study
has had a large impact on thinking about nature vs. nurture and the
role they play in our decision-making process. When people
have studied diseases in identical twins, they have not found an
absolute concordance. For example, diseases like cancer,
Alzheimer's Disease, autoimmune diseases and many others are often
expressed in one twin and not in the other, suggesting at least a
combined influence of genetics and environment on the expression of
the disease and perhaps even a strong role for
environment. That environment can be physical (such as a virus
infection or an environmental insult of some sort) or physiologic
(stress, disease, etc.).
[14] In any case, for many diseases, the role of nature vs.
nurture is not clear at this point. On the other hand, a
variety of other behaviors that one would not have anticipated were
identical in twins raised apart. For example, they show
similar selections in clothing (including choice of prints and
colors), the same lawn furniture on the front yard of the house,
and even the choice of names for their offspring. Is there a
role for genetics in these choices that we would have considered to
be predominantly environmentally influenced? The twin studies
suggest that this is the case, and further studies in genetics are
likely to help determine what decisions we make are influenced by
our genetics.
[15] In an effort to understand social behaviors,
geneticists have used several approaches to identify the genes
involved in their regulation. The Honeybee Sequencing
Consortium recently reported over 22 genes that are involved in
social interactions among honeybees and, while many of these genes
are shared with the fruit fly, they are expressed differently in
the two species resulting, it is believed, in the social behavior
of honeybees. These genes are involved in a variety of
different functions including vision, circadian rhythm, thermal
regulation and learning/memory. Many of these genes are
similar to those found in humans and may provide insight into human
social behavior.
[16] Another project perhaps nearer to our hearts is the
Dog Genome Project aimed at sequencing the dog genome and
identifying aspects of the genome associated with particular
behaviors we find in dogs. Because dogs live in the same
environment as we do, eat similar food, some even watch TV and
become couch potatoes, it is hoped that studying dogs will help us
uncover important aspects of human social behavior. In an
effort to use dogs to help humans with a variety of tasks, dogs
have been specially bred for particular traits; some help in
herding, others like my Jessie (Fig. 2)
were bred to chase foxes out of their holes during fox hunts, and
still others were trained as blood hounds to find prey that had
been shot. Even when dogs are not employed in these functions,
they still retain these traits. Many who have sheep dogs but
no sheep claim that their dogs will work tirelessly to herd small
children or other pets into a circle. These functions are
likely to be genetically founded because it seems that they have
been bred into the animals, and it is hoped that the doggy genome
project will identify what some of these genes are. To date,
the boxer dog and the standard poodle have been totally sequenced,
and several other dog strains are on the list to be completed soon,
while ribosomal genes (short segments of genome that can be used to
track genetic closeness between species and subspecies) have been
sequenced in a vast array of dog breeds. So far, we have
learned which dog breeds are closely related and which ones are
not; there were a few surprises in these studies and some dog
breeds thought to be very ancient were found to be of much more
recent origin. One recent study has shown that all body size
differences in the various strains of dogs are related to a single
gene and its expression-the insulin-like growth factor 1
gene. This gene had already been known to be involved in size
regulation in many species (including humans), but what was
surprising was the identification of a single gene as being solely
responsible for the size differences of all dog breeds (3).
[17] As we begin to uncover other information from the
various genome projects and the relationship of that information to
humans, we are likely to find genes that influence human behavior,
that contribute to human social and anti-social behavior. How
much of our behavior is genetic and how much is environmentally
determined? How much of our personality is genetic? From
a religious perspective we are often taught to overcome the bad
influences we have encountered in our environments-whether they are
school, family or work. Are we now also to work to overcome
our genetic makeup as well? In light of genetics and its role
on human behavior, what is sin?
[18] Perhaps in order to understand our humanity we need to
examine humans from a non-genetic context. Sergei Bulgakov
noted the following about the human condition today: "The
stumbling block for contemporary thought ¼is
that the history of the world preserves traces neither of Eden nor
of the perfection of the original man, which is why the biblical
story is considered only a naïve
legend¼.What should one's attitude be toward
this story in the face of the existing critique? One can say
that the remembrance of an edenic state and of God's garden is
nevertheless preserved in the secret recesses of our
self-consciousness, as an obscure anamnesis of another
being¼.." (4).
How far is too far? (or should we limit
technology?)
[19] New technologies are providing us with tools to treat
and diagnose disease not only at the level of the whole organism
but down to the single cell. We are developing approaches to
manipulate cells and genomes and perhaps ultimately even
humanity. There is a very rapid movement from technology to
application, and this speed makes it extremely difficult to limit
technology as it is being developed. Most often, socially
applied limitations of technology occur at the level of the
application of the procedure rather than at the development of the
tool itself; while most technology is morally neutral, its
applications can be both/either morally positive or negative and
therefore belong to the area of life that society strives to
control.
[20] Science in general is a technology-driven field, and
the development of only a single new approach can often have a
lasting and drastic impact. One need think only of the PCR
(polymerase chain reaction) and what it has done for forensics,
medicine, and biomedical research to see this type of
influence. Before PCR was developed, one had to use large
numbers of cells to analyze DNA; PCR technology allowed that
amplification of DNA be possible from a single cell found in a hair
follicle or a drop of blood, amplification so accurate and abundant
that the complete genome of an individual may become available from
a single cell. A simple version of this technique made it
possible to identify who were the people at crime scenes from the
hairs they left behind or dried droplets of bodily fluids, while
more elaborate uses of this technique allow scientists to
understand complex genetic processes occurring on a single cell
level instead of requiring a large cell population. We see
similar examples of this variation in the use of technology in our
every-day lives-massive use of laptop and home computers,
development of the iPod, cell phones, etc. on one hand, and
supercomputing machines used by computer scientists on the
other. It is in the arena of everymen's technology that the
world and society have become stratified into those who have the
technology and those who "don't do it" or even "can't do it."
[21] Here are a few major examples of biomedical technology
that is currently impacting science and is soon likely to impact
the society at large:
(1) Structural biology. This technology has allowed
for the identification of three-dimensional structures for many of
the most important proteins in the human body. The
identification of the actual shape that a protein has while it is
in the body has allowed for the design of drugs to target that
protein and lead to the field of rational drug design. Drugs
that inhibit the HIV, the virus that causes AIDS, were designed
based on their ability to bind to one of the major proteins of the
virus and inhibit it during viral infection. This was done in
part by examining the three-dimensional structure of the protein,
looking at how other proteins bind to that structure and then
developing a drug that mimics (and competes with) those binding
proteins. The selection process is done repeatedly in an
effort to develop the best drug that inhibits the viral protein but
has little impact on the remainder of cell function.
[22] (2) Genome technology and
proteomics. One component of the Human Genome Project was to
develop technologies that would allow for rapid sequencing of the
genome and also rapid recognition of sequences that represent
genes, as well as finding out in which tissues/organs that gene is
expressed and when it is silent. Gene chip technology was
developed for these purposes, and it allowed for the simultaneous
screening of the 38,000+ genes in the human genome for expression
patterns (when they are turned on and turned off) in a single
overnight experiment. This approach generates a large amount
of data that requires weeks for complex computer analyses; these
experiments can classify tumors for responsiveness to various
therapies, identify mutations that make a tissue more prone to
tumor development, etc. Fig. 3
shows the results from an experiment in my laboratory where we
screened the human genome for genes that are turned on in response
to radiation therapy and particular chemotherapeutic
regimens. Each line represents a single gene that is turned on
in response to the therapy. This diagram shows the complexity
of the data that are generated and yet the ease in obtaining so
much information in a single experiment. While genomics
technologies have examined the DNA and RNA, proteomics looks at
large numbers of proteins at the same time and relates that to the
genome of the individual.
[23] (3) Beginning of life and stem cell
technologies. The advent of in vitro fertilization (IVF)
provided a solution for couples who could not have children
naturally. With the development of this technology, however,
came the development of other beginning of life approaches
including cloning and stem cell research. While these
technologies were developed in response to reproductive issues and
to study specific scientific questions, it soon became apparent
that the use of stem cells for treatment of problems like
Alzheimer's Disease, diabetes, spinal cord damage, and others could
provide hope for individuals in serious medical conditions with
little hope for cure. This also became controversial because
some religious groups argued that embryos should not be sacrificed
for others even if the result was a cure for a debilitating
condition. This battle continues today as scientists attempt
to develop acceptable approaches for the generation of stem cells
and some religious groups express concerns about these very
approaches. Stem cell research has great potential for
providing cures for diseases that have no known therapies, and we
are likely to see continued developments and research in this
area.
[24] (4) Nanotechnology. The eye of a
needle is 1mm in size, a single red blood cell is 5 microns, a
typical virus is 75 nanometers, and a DNA helix is 2 nanometers in
width. Nanotechnology is the use of materials that are smaller
than 100 nanometers in size in at least one dimension and that may
or may not have altered chemical properties when they are of this
size. Why is nanotechnology becoming so important right
now? Most cells are microns in size (thousands of nanometers);
when we synthesize devices that are much smaller than cells, we can
use these as tools to manipulate cells. Blood vessels in
tumors, for example, are 20-500 nanometers wide; what materials can
we synthesize this small that can reach a tumor through these tiny
blood vessels tumor vasculature is as wide as the rest but more
leaky? What types of agents can we design that can enter a
cell and alter cellular function? Nanodevices hold this
promise-they are small in size and they can be engineered with
organic matter to produce hybrid materials with hybrid
functions. Fig. 4
provides a schematic diagram of how a nanodevice can be used to
provide a single agent that delivers a drug to a particular type of
cancer cell while at the same time providing imaging capabilities
that can detect particular genetic mutations. Nanodevices are
currently being explored as new imaging tools for diseases,
therapeutic agents for cancer and other diseases, drug delivery
systems, and more (5).
[25] All of the above technologies are going to continue to
develop at a very rapid rate, making it difficult to regulate these
areas of research. At this point in time, regulation occurs
generally at the level of the application of the technology, and
often after an application has been attempted that is considered
dangerous. For example, while cloning technology may have
benefits for stem cell research, regulation of cloning was not
considered imperative until "attempts" were made at cloning human
beings; while these attempts were not successful, their potential
use scared regulatory bodies into making legislation that would
prevent human cloning. Of course, this legislation generally
applies to what can be done with government funds, not what can be
done with private funding. The impact of the religious
communities on the regulation is minimal, occurring only through
the public dialogue rather than a specific engagement of the
religious communities to address the matter.
[26] In reflecting on the applications of technology,
perhaps it is wise to consider the words of St. Basil the Great who
wrote in ancient times about medicine, the technology of his
day: "Medicine is a gift from God even if some people do not
make the right use of it. Granted, it would be stupid to put
all hope of a cure in the hands of doctors, yet there are people
who stubbornly refuse their help altogether." Elsewhere in the
same article he wrote: "All the different sciences and
techniques have been given us by God to make up for the
deficiencies of nature¼Not by chance does the
earth produce plants that have healing properties. It is
clearly evident that the Creator wants to give them to us to use."
(6).
Who are we?
[27] Perhaps the most important question is how new
scientific knowledge will impact our concepts of ourselves as human
beings. In the context of our evolution and our genetics, it
is becoming more difficult to define exactly what is a human
being. How much are we the human population and how much are
we individuals? We are animals, but are we also different than
animals? While it is clear that science is impacting these
issues, it is also likely that the answers to the question of human
identity are not in science-although they may be made more
difficult because of the science that is being done.
[28] One issue that has significantly impacted this
question has been the DNA sequence comparison between chimpanzees
and humans. The sequence of the chimpanzee genome has shown
that there is over 98% identity between humans and chimps (humans
amongst themselves show a 99% identity), and a comparison at the
protein sequence level has shown that there are small amino acid
differences in some proteins; most of these appear to be
conservative changes that do not make a vast difference in the
function of the protein. Because of apparent differences in
cognitive functions, much work has been done comparing chimp and
human brains for the genes that are turned on and turned off during
brain development and the timing of these events. In general,
over 80% of genes in the human brain are produced in larger
quantity than the same genes in the chimp, suggesting that
differences in human and chimp brain function may be at least in
part caused not by different proteins but rather larger quantities
of the same proteins. Some scientists have attempted to
examine expression of all neural genes and their changes, and
estimates are that some 100-4000 genes have differences in gene
expression when comparing chimps and humans (7). Despite these
differences, the striking similarities between chimps and humans
are remarkable and brings to mind questions of who we as humans are
compared to our nearest living relative. This question is even
more dramatic when we consider extinct proto-humans like
Neaderthals. Recent experiments have examined sequences of
mitochondrial DNA (separate from our usual genetic material, found
in organelles in the cell called mitochondria) from Neanderthals
and compared them to mitochondrial DNA of modern humans; these
sequences demonstrate that Neanderthal mitochondrial sequences fit
into the range of sequence variation we find in humans today
(8). Based on all of this, it seems it is going to be
difficult to come up with a scientific definition of what it is to
be human.
[29] One thing that is difficult to capture in genes is the
fact that humans have a cultural heritage that we pass on from one
generation to the next. We certainly pass on our genetic
heritage to future generations in our children and grandchildren,
but we also pass on a cultural heritage that does not
require genetics. Evolution operates at the level of the
populations, and they (populations) preserve the genes of the most
reproductively fit individuals; but humans have societal groups
that are different than populations, with rules of behavior that
alter "reproductive fitness" of individuals. At the same time,
very often individuals who leave no progeny make significant
contributions to the cumulative transmission of experience through
millennia. Humans can adapt to their environment quickly by
changing the environment to suit their needs. Birds had to
evolve the ability to fly through genetic changes that took
millions of years; humans could create planes to meet the same
needs.
[30] Humans need to be placed in the context of
environment. We share elements and materials with the earth,
being made of carbon, water, oxygen, etc. We share genes and
genetic pathways with other species including our protein encoding
genetic code which is identical for all species on earth. We
are unique in some aspects that are difficult to
define¼ Our creativity? Our
responsibility? Our love? Like all species on earth, we
are products of our environment and our genes, but we are the part
of creation that contemplates. The answer to who we are
is not likely to be found in science-we must look elsewhere,
and it is religious communities that can help in this
goal. The word "anthropos," which is Greek for human, comes
from the word "anathrein" which means to "look up." Humans,
unlike most animals, look up, are heavenly yet earthly, spiritual
yet material. Using St. John Chrysostom as a source, Kallistos
(Ware) says "Our human task is to be syndesmos and gephyra,
the bond and bridge of God's creation." (9) To further this
point, it is useful to reflect upon comments by John Zizioulas on
this issue: "The belief in human superiority received a blow
from Darwinism when Charles Darwin proved that not only humans but
also animals, although to a lesser degree, are capable of
thinking. So if the human is in the image of God, God must be
so due to other capabilities than his/her ability to think, and it
is these capabilities which we must learn to value."
(10)
[31] Who are we? Perhaps that is the quest that
humanity has been driven to answer throughout all the
millennia.
1. Watson, J. D., Baker, T. A., Bell, S. P. and Gann.
A. Molecular Biology of the Gene (5th Edition),
Benjamin Cummings Publishing, 2003.
2. Patriarch Ignatius IV, 1989 quoted in "Orthodox Patriarchs
and Hierarchs Articulate a Theology of Creation," pamphlet
published by the Society of the Transfiguration, 2002.
3. H. G. Parker et al., Science (2004) 304: 1160-1164
4. Bulgakov, S. The Bride of the Lamb, Grand Rapids, MI, Wm
B Eerdmans Publishing Co., 2002.
5. Cancer vol 107, no 3, pp. 459-466
6. Basil the Great, The Greater Rules, #55
7. Pennisi, E., "Mining the Molecules that Made our Mind",
Science (26 September 2006) 313(5795): 1908-1911.
8. Green, R., Krause, J., Ptak, S. E., Briggs, A. W.,
Ronan, M. T., Simons, J. F., Du, L., Engholdm, M., Rothberg, J. M.,
Paunovic, M., and Paaho, S. "Analysis of one million base
pairs of Neaderthal DNA," Nature (2006) 444: 330-336.
9. Ware, Kallistos. Through the Creation to the
Creator, London, UK, Friends of the Centre, 1997
10. Zizioulas, J. quoted in "Orthodox Patriarchs and
Hierarchs Articulate a Theology of Creation," pamphlet published by
the Society of the Transfiguration, 2002.
© February 2008
Journal of Lutheran Ethics (JLE)
Volume 8, Issue 2